ストックスクリーナーアプリを入手
0.8467
1.44%
-0.0124
アフターアワーズ：
.84
-0.0067
-0.79%
前日終値:
$0.8591
開ける：
$0.84
24時間の取引高:
84,835
Relative Volume:
0.01
時価総額：
$19.55M
収益：
-
当期純損益:
$-16.28M
株価収益率:
-0.0609
EPS:
-13.91
ネットキャッシュフロー:
$-13.75M
1週間 パフォーマンス:
-8.70%
1か月 パフォーマンス:
-24.40%
6か月 パフォーマンス:
+16.63%
1年 パフォーマンス:
-66.40%
1日の値動き範囲:
$0.8319
$0.86
1週間の範囲:
$0.8319
$0.9183
52週間の値動き範囲:
$0.281
$3.85
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
名前
Pasithea Therapeutics Corp
セクター
電話
(702) 514-4174
住所
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
KTTA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.8467 | 19.84M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Pasithea Therapeutics Corp (KTTA) 最新ニュース
Performance Recap: Should I average down on WRAP stockMarket Movers & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Aug Shorts: Can Pasithea Therapeutics Corp sustain earnings growth2025 Bull vs Bear & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
How does SWVL compare to its peersEarnings Recap Summary & High Yield Stock Recommendations - baoquankhu1.vn
Published on: 2026-01-22 13:20:30 - baoquankhu1.vn
Aug Big Picture: Is Finward Bancorp benefiting from interest rate changes2025 Investor Takeaways & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Pasithea Therapeutics regains Nasdaq compliance - MSN
New Highs: Can Pasithea Therapeutics Corp grow without external fundingJuly 2025 Closing Moves & Breakout Confirmation Trade Signals - baoquankhu1.vn
Pasithea Therapeutics: Buy Rating on Differentiated PAS-004, 2026 Clinical Catalysts, and Strengthened Cash Runway - TipRanks
Pasithea provides updates on clinical trials for MEK inhibitor drug By Investing.com - Investing.com Canada
Pasithea provides updates on clinical trials for MEK inhibitor drug - Investing.com
Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines - Investing News Network
Pasithea Therapeutics Updates Clinical Trial Timelines for PAS-004 in Neurofibromatosis and Advanced Cancer - Quiver Quantitative
Risk Hedge: Is Pasithea Therapeutics Corp Equity Warrant impacted by rising ratesMarket Growth Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Pasithea Therapeutics Corp. (KTTA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Pasithea Therapeutics (NASDAQ:KTTA) Stock Rating Upgraded by Wall Street Zen - Defense World
How Pasithea Therapeutics Corp. Equity Warrant stock reacts to oil pricesJuly 2025 EndofMonth & Stepwise Trade Execution Plans - ulpravda.ru
How analysts rate Pasithea Therapeutics Corp. stock today2025 Trade Ideas & Weekly Chart Analysis and Trade Guides - ulpravda.ru
Why hedge funds are buying Pasithea Therapeutics Corp. stock2025 Momentum Check & Verified Swing Trading Watchlists - ulpravda.ru
What is the fair value of Pasithea Therapeutics Corp. Equity Warrant stock now2025 Bull vs Bear & Daily Growth Stock Tips - ulpravda.ru
Why Pasithea Therapeutics Corp. stock remains undervaluedJuly 2025 Selloffs & Daily Entry Point Trade Alerts - Улправда
How Pasithea Therapeutics Corp. stock benefits from strong dollar2025 Risk Factors & Short-Term High Return Ideas - Улправда
How Pasithea Therapeutics Corp. stock compares to industry benchmarks2025 Investor Takeaways & Free Expert Verified Stock Movement Alerts - ulpravda.ru
Why Did KTTA Stock Soar A Whopping 48% Today? - MSN
Is Pasithea Therapeutics Corp. Equity Warrant stock a dividend growth opportunity2026 world cup usa national team quarterfinals star players transition play group prediction analysis - ulpravda.ru
Will Pasithea Therapeutics Corp. Equity Warrant stock deliver shareholder value2026 world cup usa national team quarterfinals young talents transition play knockout prediction tactical review - ulpravda.ru
Pasithea Therapeutics Corp Stock Analysis and ForecastMomentum Trading Signals & Big Profit Low Capital - earlytimes.in
Is Pasithea Therapeutics Corp. overvalued or undervalued? - MarketsMojo
Pasithea Therapeutics Stock Soars After Positive Data From Cancer Drug Trial: Retail’s Elated - MSN
Can Pasithea Therapeutics Corp. stock hit analyst price targetsWeekly Stock Analysis & Safe Entry Momentum Stock Tips - Улправда
What sentiment indicators say about Pasithea Therapeutics Corp. Equity Warrant stockJuly 2025 Pullbacks & Reliable Entry Point Trade Alerts - Улправда
Is Pasithea Therapeutics Corp. Equity Warrant stock cheap at current valuationTrade Volume Summary & Weekly Sector Rotation Insights - Улправда
Will Pasithea Therapeutics Corp. stock return to pre crisis levelsWeekly Investment Report & Fast Gaining Stock Strategy Reports - Улправда
What hedge fund activity signals for Pasithea Therapeutics Corp. Equity Warrant stockLong Setup & Accurate Entry and Exit Point Alerts - Улправда
Recap Report: What sentiment indicators say about Pasithea Therapeutics Corp. Equity Warrant stockTrade Analysis Report & Daily Oversold Stock Bounce Ideas - Улправда
Pasithea Therapeutics Regains Nasdaq Compliance - The Globe and Mail
Pasithea Therapeutics regains Nasdaq compliance with minimum bid price rule - Investing.com
Pasithea Therapeutics (NASDAQ: KTTA) back in Nasdaq bid price compliance - Stock Titan
Market Review: Is Pasithea Therapeutics Corp stock a contrarian buy2025 Top Gainers & Safe Capital Allocation Plans - moha.gov.vn
LEAHY EMER Insider Trades - Nasdaq
SCHNEIDERMAN DANIEL H Insider Trades - Nasdaq
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Pasithea Therapeutics Corp - GuruFocus
Pasithea Therapeutics (NASDAQ:KTTA) Upgraded at Zacks Research - Defense World
What is HC Wainwright’s Forecast for KTTA FY2025 Earnings? - Defense World
HC Wainwright Begins Coverage on Pasithea Therapeutics (NASDAQ:KTTA) - Defense World
Pasithea Therapeutics Corp (KTTA) 財務データ
収益
当期純利益
現金流量
EPS
Pasithea Therapeutics Corp (KTTA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
Nov 28 '25 |
Buy |
0.75 |
33,333 |
25,000 |
73,334 |
| Dumesnil Simon | Director |
Nov 28 '25 |
Buy |
0.75 |
33,333 |
25,000 |
35,833 |
2.09%
0.48%
大文字化:
|
ボリューム (24 時間):